Table II.
Visual analogue scale (VAS) score before and after treatment
| Study | Mesotherapy group |
Control group |
||||
|---|---|---|---|---|---|---|
| Subjects, n | Baseline | Post-treatment | Subjects, n | Baseline | Post-treatment | |
| Costantino et al., 2011 (26) | 42 | 90.00 ± 10.0 | 32.5 ± 7.5 | 42 | 85.0 ± 13.0 | 35.5 ± 5.5 |
| Saad et al., 2019 (33) | 25 | 71.0 ± 11.0 | 16.0 ± 5.0 | 25 | 74.0 ± 9.0 | 30.0 ± 14.0 |
| Kocak, 2019 (34) | Missing data | |||||
| Monticone et al., 2004 (35) | 11 | 70.0 | 2.0 | 11 | 70.0 | 70.0 |
| Moretti et al., 2005 (36) | 40 | 94.0 ± 5.0 | 67.00 ± 11.00 | 83 | 87.0 ± 30.0 | 20.0 ± 11.0 |
| Saggini et al., 2015 (37) | 60 | 70.0 ± 10.5 | 20.0 ± 3.5 | 57 | 75.0 ± 18.5 | 30.0 ± 11.0 |
| Senara et al., 2015 (38) | 40 | 84.0 ± 8.8 | 4.75 ± 5.5 | 40 | 83.88 ± 8.7 | 9.0 ± 8.1 |
| Yang et al., 2018 (39) | 18 | 70.0 ± 12.0 | 20.0 ± 12.0 | 18 | 75.0 ± 15.0 | 50.0 ± 13.0 |